Inflammation Mediated by JNK in Myeloid Cells Promotes the Development of Hepatitis and Hepatocellular Carcinoma
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The cJun NH2-terminal kinase (JNK) signaling pathway is required for the development of hepatitis and hepatocellular carcinoma. A role for JNK in liver parenchymal cells has been proposed, but more recent studies have implicated non-parenchymal liver cells as the relevant site of JNK signaling. Here, we tested the hypothesis that myeloid cells mediate this function of JNK. We show that mice with myeloid cell-specific JNK deficiency exhibit reduced hepatic inflammation and suppression of both hepatitis and hepatocellular carcinoma. These data identify myeloid cells as a site of pro-inflammatory signaling by JNK that can promote liver pathology. Targeting myeloid cells with a drug that inhibits JNK may therefore provide therapeutic benefit for the treatment of inflammation-related liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046 · cited 2×
“, 2009) and lactic acid produced by tumor cells (Colegio et al., 2014), that regulate signaling pathways that control macrophage polarization (Zhou et al.”
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764 · cited 2×
“…are significant because TNF-a, IL-1b, and IL-6 promote hepatic inflammation, hepatitis, and Cell Reports 15, 19–26, April 5, 2016 23 HCC development (Park et al., 2010; Negash and Gale, 2015) and CCL17/CCL22 can act as chemoattractants for tumorassociated Foxp3+ Tregs that regulate anti-tumor…”
Regulatory T cells in tumor immunity
Nishikawa, H., & Sakaguchi, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25429 · Cited by 944 · cited 2×
“…and IL-6 promote hepatic inflammation, hepatitis, and Cell Reports 15, 19–26, April 5, 2016 23 HCC development (Park et al., 2010; Negash and Gale, 2015) and CCL17/CCL22 can act as chemoattractants for tumorassociated Foxp3+ Tregs that regulate anti-tumor immunity (Nishikawa and Sakaguchi, 2010).”
Roles for chemokines in liver disease
Marra, F., & Tacke, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.06.043 · Cited by 829 · cited 1×
“The JNK-mediated promotion of hepatic infiltration by monocytes and neutrophils (Figure 1) may be caused by chemokines (Marra and Tacke, 2014).”
Zhou, D., Huang, C., Lin, Z., Zhan, S., Kong, L., Fang, C., & Li, J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.004 · Cited by 778 · cited 2×
“The JNK signaling pathway is implicated in the control of macrophage polarization (Zhou et al., 2014).”
Chang, L., Kamata, H., Solinas, G., Luo, J.-L., Maeda, S., Venuprasad, K., Liu, Y.-C., & Karin, M. (2006) · Cell · doi:10.1016/j.cell.2006.01.021 · Cited by 706 · cited 2×
“, 2003), although subsequent studies indicated that JNK1 may play a primary role in this response (Kamata et al., 2005; Chang et al., 2006).”
IKKβ Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating TNFα
Maeda, S., Chang, L., Li, Z.-W., Luo, J.-L., Leffert, H., & Karin, M. (2003) · Immunity · doi:10.1016/s1074-7613(03)00301-7 · Cited by 286 · cited 2×
“For example, Mapk8 / and Mapk9 / mice were reported to be resistant to hepatitis (Maeda et al., 2003), although subsequent studies indicated that JNK1 may play a primary role in this response (Kamata et al., 2005; Chang et al., 2006).”
Cited by
JNK at the crossroad of obesity, insulin resistance, and cell stress response
Solinas, G., & Becattini, B. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2016.12.001 · Cited by 422
Nrf2 Regulates Oxidative Stress and Its Role in Cerebral Ischemic Stroke
Wang, L., Zhang, X., Xiong, X., Zhu, H., Chen, R., Zhang, S., Chen, G., & Jian, Z. (2022) · Antioxidants · doi:10.3390/antiox11122377 · Cited by 354
Kern, L., Mittenbühler, M., Vesting, A., Ostermann, A., Wunderlich, C., & Wunderlich, F. (2018) · Cancers · doi:10.3390/cancers11010024 · Cited by 331
“This finding is further emphasized by a study demonstrating that myeloid-specific JNK deficiency reduces the expression of inflammatory cytokines and hepatic infiltration of immune cells, thereby suppressing the development of HCC [67].”
BackgroundWin, S., Than, T. A., Zhang, J., Oo, C., Min, R. W. M., & Kaplowitz, N. (2018) · Hepatology · doi:10.1002/hep.29689 · Cited by 171
“JNK deficiency in myeloid cells significantly decreased liver mass and tumor size, but tumor number was not different.((61)) Further evaluation of DEN-induced liver tumor development in hepatic conditional deletion of JNK1, JNK2, or JNK112 mice is required to examine the role of JNK in DEN-induced hepatocyte apoptosis…”
BackgroundJNK regulates muscle remodeling via myostatin/SMAD inhibition
Lessard, S. J., MacDonald, T. L., Pathak, P., Han, M. S., Coffey, V. G., Edge, J., Rivas, D. A., Hirshman, M. F., Davis, R. J., & Goodyear, L. J. (2018) · Nature Communications · doi:10.1038/s41467-018-05439-3 · Cited by 119
Self-citationYoon, J.-S., & Lee, C.-W. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00883-0 · Cited by 14
Nrf2 signaling pathway: focus on oxidative stress in osteoporosis
Gu, H.-Y., Liu, N., Lin, F.-X., & Yin, J. (2025) · Osteoporosis International · doi:10.1007/s00198-025-07592-0 · Cited by 10
Metadata
- Authors
- Han, M. S., Barrett, T., Brehm, M. A., & Davis, R. J.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 15
- Issue
- 1
- Pages
- 19-26
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W2308775428
- Cited by
- 74
- References
- 8
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.